network 13 home
providers
patients
FDA Medwatch
Complaints and Grievance Page
Dialysis Facility Compare
Patient Rights & Responsibilities
Disaster Readiness
Network Patient
Representative Program
Upcoming Events for Patients
Other Patient Resources
Patient Advocacy Committee
Kidney Community Gatherings
Returning to Work (Vocational Rehabilitation)
Patient Newsletter
Medicare Information
Support Groups
Contact Us
ESRD Network 13 Medwatch Database
To Search the ESRD Network 13 FDA Medwatch Database click
here
.
ESRD's FDA Medwatch Listing
12/17/2012
Chantix (Varenicline): Safety Communication - Updated Safety Review On The Risk of Cardiovascular Adverse Events
12/06/2012
FDA MedWatch - Heparin: Drug Safety Communication - Important change to heparin container labels to clearly state the total drug strength
11/30/2012
FDA MedWatch - Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance
11/19/2012
FDA MedWatch - October 2012 Safety Labeling Changes includes 58 products with revisions to Prescribing Information
11/19/2012
FDA MedWatch - HeartSine Samaritan Public Access Defibrillator 300/300P: Class I Recall - Device May Intermittently Turn On and Off
11/09/2012
FDA MedWatch - Baxter Healthcare Corp. Buretrol Solution Set: Class 1 Recall - May Not Function as Expected
11/05/2012
FDA MedWatch - Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Safety Review of Post-Market Reports of Serious Bleeding Events
10/31/2012
FDA MedWatch - Ameridose, LLC: Recall of Unexpired Products in Circulation
10/29/2012
FDA MedWatch - Hospira Symbiq Infusion System Touchscreen: Class 1 Recall - May Not Respond to Selection
10/26/2012
FDA MedWatch - Fungal Meningitis Outbreak - FDA Reviewed, Corrected, and Reposted NECC List
First
Previous